3VJ-25083-76732 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-02-16
Dose 1 — Pfizer-BioNTech
2021-03-09
Dose 2 — Pfizer-BioNTech
2021-04-23
Registered in v-safe
2021-04-23
Survey response — day 42, dose 2
MedDRA: Heavy menstrual bleeding — Feeling: Good

Free text: Early heavy period (2.5 weeks early) then another 8-day heavy period 4 weeks later

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-10
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-11-10
Dose 3 — Pfizer-BioNTech
2022-03-13
Survey response — 12 months, dose 2
MedDRA: Ageusia — Feeling: Good

Free text: Loss of taste

MedDRA releases: 2024-11 · check-in free text available
2022-11-12
Survey response — 12 months, dose 3
MedDRA: Bacterial infection, COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: COVID and a subsequent bacterial infection

MedDRA releases: 2024-11 · check-in free text available
2022-11-12
Report sent to call center — 12 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-11-14
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-02-16	Pfizer-BioNTech
2	2021-03-09	Pfizer-BioNTech
3	2021-11-10	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2022-11-12	Unsuccessful

Free text

Release 7 — day 42, dose 2

2021-04-23

Symptoms: Early heavy period (2.5 weeks early) then another 8-day heavy period 4 weeks later

Release 11 — 12 months, dose 2

2022-03-13

Symptoms: Loss of taste

Release 12 — 12 months, dose 3

2022-11-12

Symptoms: COVID and a subsequent bacterial infection

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Ageusia	·	·	✓
SD	Bacterial infection	·	·	✓
SD	COVID-19	·	·	✓
SD	Heavy menstrual bleeding	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release